12-28-2　ⓔ文献

  1. 日本肝胆膵外科学会編：臨床・病理胆道癌取扱い規約 第6版，金原出版，2013．

  2. Shimada K, Yanagisawa J, et al: Increased lysophosphatidylcholine and pancreatic enzyme content in bile duct of patients with anomalous pancreaticobiliary ductal junction. Hepatology, 1991; 13: 438–444.

  3. Tanaka A, Takamori Y, et al: Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int, 2008; 28: 514–520.

  4. Kubo S, Nakanuma Y, et al: Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J Hepatobiliary Pancreatic Sci, 2014; 21: 479–488.

  5. Xia J, Jiang SC, et al: Association between liver fluke infection and hepatobiliary pathological changes: a systematic review and meta–analysis. PloS One, 2015; 17: e0132673.

  6. 国立がん研究センター，がん対策情報センター：2019年のがん統計予測．http://ganjoho.jp/public/statistic/pub/short_pred. html

  7. Aljiffry M, Abdulelah A, et al: Evidence–based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg, 2009; 208: 134–147.

  8. DeOliveria ML, Cuningham SC, et al: Cholangiocarcinoma: thirty–one–year experience with 564 patients at a single institution. Ann Surg, 2007; 245: 755–762.

  9. Cha JM, Kim MH, et al: Clinicopathological review of 61 patients with early bile duct cancer. Clin Oncol, 2006; 18: 669–677.

  10. Unno M, Okumoto T, et al: Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg, 2007; 14: 434–440.

  11. Ishihara S, Horiguchi A, et al: Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci, 2016; 23:149–157.